Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients

NCT01820767 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Paricalcitol
DRUG: Paricalcitol, atorvastatin
DRUG: Atorvastatin

Sponsor

Ricardo Mouzo Mirco